6533b7d3fe1ef96bd1261306
RESEARCH PRODUCT
Neutropenia tóxica tras ocrelizumab sin recurrencias posteriores tras continuar el tratamiento
F. Gascon-gimenezJ.a. Domínguez-moránA. Teruel-casasusJ.m. Láinezsubject
business.industryMedicineNeurology (clinical)businessyear | journal | country | edition | language |
---|---|---|---|---|
2021-04-01 | Neurology Perspectives |